Mesoblast (MESO) Revenue (2016 - 2024)
Historic Revenue for Mesoblast (MESO) over the last 10 years, with Q2 2024 value amounting to -$10.3 million.
- Mesoblast's Revenue fell 58242.17% to -$10.3 million in Q2 2024 from the same period last year, while for Jun 2025 it was -$10.3 million, marking a year-over-year decrease of 6534.21%. This contributed to the annual value of $17.2 million for FY2025, which is 19139.27% up from last year.
- According to the latest figures from Q2 2024, Mesoblast's Revenue is -$10.3 million, which was down 58242.17% from $2.1 million recorded in Q2 2023.
- In the past 5 years, Mesoblast's Revenue registered a high of $12.2 million during Q1 2020, and its lowest value of -$10.3 million during Q2 2024.
- Moreover, its 5-year median value for Revenue was $2.0 million (2022), whereas its average is $1.9 million.
- In the last 5 years, Mesoblast's Revenue soared by 107092.13% in 2020 and then plummeted by 58242.17% in 2024.
- Quarter analysis of 5 years shows Mesoblast's Revenue stood at $2.2 million in 2020, then increased by 6.34% to $2.4 million in 2021, then fell by 10.45% to $2.1 million in 2022, then rose by 0.23% to $2.1 million in 2023, then plummeted by 582.42% to -$10.3 million in 2024.
- Its Revenue stands at -$10.3 million for Q2 2024, versus $2.1 million for Q2 2023 and $1.9 million for Q1 2023.